Pro Dex Stock Today
| PDEX Stock | USD 26.60 1.45 5.17% |
Performance13 of 100
| Odds Of DistressLess than 4
|
Pro Dex is trading at 26.60 as of the 25th of September 2024; that is 5.17 percent decrease since the beginning of the trading day. The stock's open price was 28.05. Pro Dex has only four percent chance of going through some form of financial distress over the next 2 years and had a good performance during the last 90 days. Equity ratings for Pro Dex are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of October 2022 and ending today, the 25th of September 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 18th of August 1995 | Category Healthcare | Classification Health Care |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company was founded in 1978 and is headquartered in Irvine, California. Pro Dex operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 3.36 M outstanding shares of which 4.99 K shares are at this time shorted by private and institutional investors with about 0.58 trading days to cover. More on Pro Dex
Moving together with Pro Stock
Moving against Pro Stock
Pro Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Richard Kirk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPro Dex can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pro Dex's financial leverage. It provides some insight into what part of Pro Dex's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pro Dex (PDEX) is traded on NASDAQ Exchange in USA. It is located in 2361 McGaw Avenue, Irvine, CA, United States, 92614 and employs 146 people. Pro Dex is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 89.32 M. Pro Dex conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 3.36 M outstanding shares of which 4.99 K shares are at this time shorted by private and institutional investors with about 0.58 trading days to cover.
Pro Dex currently holds about 1.6 M in cash with 6.2 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.44.
Check Pro Dex Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Pro Dex is $89.32 Million. Pro Dex has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Pro Ownership Details
Pro Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 11.5 K | |
| State Street Corp | 2024-06-30 | 10.6 K | |
| Perritt Capital Management Inc. | 2024-06-30 | 6 K | |
| Ubs Group Ag | 2024-06-30 | 3.6 K | |
| Fmr Inc | 2024-06-30 | 2.9 K | |
| Global Retirement Partners, Llc. | 2024-06-30 | 1000 | |
| Tower Research Capital Llc | 2024-06-30 | 543 | |
| Goss Wealth Management Llc | 2024-06-30 | 416 | |
| Northwestern Mutual Wealth Management Co | 2024-06-30 | 263 | |
| Vanguard Group Inc | 2024-06-30 | 123.7 K | |
| Punch & Associates Inv Mgmt Inc | 2024-06-30 | 75.5 K |
Pro Dex Historical Income Statement
Pro Stock Against Markets
Pro Dex Corporate Executives
Elected by the shareholders, the Pro Dex's board of directors comprises two types of representatives: Pro Dex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pro. The board's role is to monitor Pro Dex's management team and ensure that shareholders' interests are well served. Pro Dex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pro Dex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alisha Charlton | CFO Secretary | Profile |
Additional Tools for Pro Stock Analysis
When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.